Therapeutic Goods (Medical Devices) Regulations 2002

1. Overview

The Therapeutic Goods (Medical Devices) Regulations 2002 (the 2002 Regulations) form the legislative framework that governs the supply, manufacture, import, export, and clinical use of medical devices in Australia. Administered by the TGA under the Therapeutic Goods Act 1989, the Regulations aim to protect public health while facilitating access to safe and effective medical devices.

Key objectives include:

• Ensuring devices meet essential safety and performance standards.
• Providing a riskbased classification system.
• Establishing conformity assessment pathways.
• Mandating postmarket surveillance and reporting.
• Defining enforcement powers and penalties.

2. Scope & Definitions

The Regulations apply to any product that:

• Is intended for use in the diagnosis, prevention, monitoring, treatment or alleviation of disease, injury or disability.
• Has a primary intended action achieved by physical, chemical or biological means, not by pharmacological, immunological or metabolic action.

Key definitions (excerpt):

3. Classification of Devices

The Regulations adopt a fourtier riskbased classification:

1. Class I Low risk (e.g., elastic bandages).
2. Class IIa Lowtomoderate risk (e.g., dental fillings).
3. Class IIb Moderatetohigh risk (e.g., infusion pumps).
4. Class III Highest risk (e.g., implantable pacemakers).

Classification determines the level of conformity assessment required and the amount of TGA involvement.

4. Conformity Assessment Pathways

Depending on classification, the following pathways are available:

• Selfdeclaration (Class I) The supplier supplies a Declaration of Conformity and a technical file.
• Australian Conformity Assessment Body (ACAB) assessment (Class IIaIII) An accredited body evaluates the device against the Essential Principles.
• Full TGA assessment (Class III only) The TGA may require a full review of clinical data and risk management.

All devices must be listed on the Australian Register of Therapeutic Goods (ARTG) before they can be supplied.

5. Labeling, Instructions for Use & Documentation

Every medical device must carry specific labeling information, including:

• Device name and model.
• Intended purpose.
• Manufacturer or Australian sponsor details.
• Unique Device Identifier (UDI) where applicable.
• Warnings, contraindications and sterilisation instructions.

Instructions for Use (IFU) must be in clear English (or other official languages where required) and accessible to the intended user. The technical documentation often called a Device Dossier must contain design specifications, risk analysis, clinical evidence, and postmarket surveillance plans.

6. PostMarket Obligations

After a device is on the market, the supplier must:

• Maintain a postmarket surveillance system.
• Report adverse events and incidents to the TGA within prescribed timeframes.
• Implement corrective actions when safety issues are identified.
• Update the ARTG listing when significant changes occur (e.g., new indications).

The TGA conducts periodic audits and may require a postmarket clinical followup study for highrisk devices.

7. Enforcement & Penalties

The TGA has broad powers to enforce compliance, including:

• Issuing improvement or prohibition notices.
• Seizing or recalling noncompliant devices.
• Imposing fines up to AUD 1.1million for corporations and AUD 220,000 for individuals.
• Prosecuting for offences such as supplying a device without ARTG inclusion.

Compliance is monitored through routine inspections, marketplace surveillance, and mandatory incident reporting.

8. Useful Resources

• Therapeutic Goods Administration (TGA) website
• Medical Devices Hub TGA
• Compliance and Enforcement Guidance
• Australian Register of Therapeutic Goods (ARTG)